Discover a new way to find and share stories you'll loveā€¦ Learn about Reading Desk

Post Profile



Daiichi, Glaxo set up Japan venture

Japanese drugmaker Daiichi Sankyo and British peer GlaxoSmithKline are to form a 50-50 joint venture to bring new vaccines to Japan. ||| Japanese drugmaker Daiichi Sankyo and British peer GlaxoSmithKline are to form a 50-50 joint venture to bring new vaccines to Japan, targeting an underdeveloped segment of the world's second-biggest prescription drug market. News of the venture, which will likely create the top player in the Japanese vaccine market, sent shares of Japan's No.
read more

share

Copyright © 2011 Regator, LLC